Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivana Sestak

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptomsIvana Sestak, Roseann Kealy, Robert Edwards, et al.
Breast Cancer Research and Treatment|July 23, 2016
Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factorsIvana Sestak, Mitch Dowsett, Sean Ferree, et al.
Breast (Edinburgh, Scotland)|November 7, 2020
Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trialMichael J Hale, Anthony Howell, Mitch Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2017
Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I)Samuel George Smith, Ivana Sestak, Anthony Howell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
Anastrozole-Induced Carpal Tunnel Syndrome: Results From the International Breast Cancer Intervention Study II Prevention TrialFrancesco Spagnolo, Ivana Sestak, Anthony Howell, et al.
Journal of the National Cancer Institute|September 2, 2017
Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast CancerAndreas Heindl, Ivana Sestak, Kalnisha Naidoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2010
Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trialIvana Sestak, Wolfgang Distler, John F Forbes, et al.
Breast Cancer Research and Treatment|May 17, 2012
Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancerIvana Sestak, Michelle Harvie, Anthony Howell, et al.
Collegium Antropologicum|December 7, 2013
Equine seroprevalence rates as an additional indicator for a more accurate risk assessment of the West Nile virus transmissionGoran Vignjević, Ivana Vrućina, Ivana Sestak, et al.
Bone|April 28, 2019
Comparison of risedronate versus placebo in preventing anastrozole-induced bone loss in women at high risk of developing breast cancer with osteopeniaIvana Sestak, Glen M Blake, Rajesh Patel, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptomsIvana Sestak, Roseann Kealy, Robert Edwards, et al.
Breast Cancer Research and Treatment|July 23, 2016
Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factorsIvana Sestak, Mitch Dowsett, Sean Ferree, et al.
Breast (Edinburgh, Scotland)|November 7, 2020
Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trialMichael J Hale, Anthony Howell, Mitch Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2017
Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I)Samuel George Smith, Ivana Sestak, Anthony Howell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
Anastrozole-Induced Carpal Tunnel Syndrome: Results From the International Breast Cancer Intervention Study II Prevention TrialFrancesco Spagnolo, Ivana Sestak, Anthony Howell, et al.
Journal of the National Cancer Institute|September 2, 2017
Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast CancerAndreas Heindl, Ivana Sestak, Kalnisha Naidoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2010
Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trialIvana Sestak, Wolfgang Distler, John F Forbes, et al.
Breast Cancer Research and Treatment|May 17, 2012
Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancerIvana Sestak, Michelle Harvie, Anthony Howell, et al.
Collegium Antropologicum|December 7, 2013
Equine seroprevalence rates as an additional indicator for a more accurate risk assessment of the West Nile virus transmissionGoran Vignjević, Ivana Vrućina, Ivana Sestak, et al.
Bone|April 28, 2019
Comparison of risedronate versus placebo in preventing anastrozole-induced bone loss in women at high risk of developing breast cancer with osteopeniaIvana Sestak, Glen M Blake, Rajesh Patel, et al.
Pageof 7